Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00642681 · ClinicalTrials.gov registry record

Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

A clinical trial of Diabetes Mellitus and Upper Respiratory Infection, sponsored by Mannkind Corporation.

Completed
Registry status
20
Enrollment target
20
Study locations

NCT00642681 is a study of Diabetes Mellitus and Upper Respiratory Infection that has completed, run by Mannkind Corporation. The registered enrollment target is 20 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00642681, a study of Diabetes Mellitus and Upper Respiratory Infection, has completed, sponsored by Mannkind Corporation.

COMPLETED
Registry status
20 participants
Enrollment target
20
Study locations

Study Summary

Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge

Conditions Studied

Diabetes Mellitus Upper Respiratory Infection

Interventions

  • DRUG Technosphere Insulin

Study Locations (20)

RUS

  • Kemerovo State Medical Academy of Ministry of Health - Kemerovo
  • NHI Kemerovo Regional Clinical Hospital - Kemerovo
  • Russian State Medical University City Hospital # 4 - Moscow
  • RAAMS Endocrinology and Diabetology Department - Moscow

California

  • Valley Research (Norwood) - Fresno
  • Diabetes/Lipid Management and Research Center - Huntington Beach

Georgia

  • Private Practice - Decatur
  • Endocrine Research Solutions, Inc. - Roswell

Ohio

  • Rapid Medical Research Inc - Cleveland
  • Your Diabetes Endocrine Nutrition Group - Mentor

Arizona

  • Arizona Research Associates - Tuscon

Illinois

  • Cedar-Crosse Research Center - Chicago

Maryland

  • MODEL Clinical Research - Baltimore

Missouri

  • Healthcare Research - Florissant

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2007-12
Est. Completion 2008-08

Sponsor

Mannkind Corporation

42 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00642681

The ClinicalTrials.gov registry entry for NCT00642681 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Mannkind Corporation, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Technosphere Insulin is the first listed.

NCT00642681 reports 20 study locations spanning 14 distinct geographic areas - top geographies include RUS, California, Georgia.

Frequently Asked Questions

What is clinical trial NCT00642681 about?

NCT00642681 is a clinical study titled "Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge". Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge

What is the current status of trial NCT00642681?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2007-12. Estimated completion is 2008-08.

What conditions does trial NCT00642681 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Upper Respiratory Infection.

What interventions are being tested in trial NCT00642681?

The interventions under investigation include: Technosphere Insulin (DRUG).

Who is sponsoring clinical trial NCT00642681?

This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00642681 being conducted?

This trial has 20 study locations across Arizona, California, Georgia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

Upper Respiratory Infection

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.